Results 71 to 80 of about 665 (160)
Prophylactic and Therapeutic Inhibition of In Vitro SARS-CoV-2 Replication by Oleandrin [PDF]
ABSTRACT With continued expansion of the COVID-19 pandemic, antiviral drugs are desperately needed to treat patients at high risk of life-threatening disease and even to limit spread if administered early during infection. Typically, the fastest route to identifying and licensing a safe and effective antiviral drug is
Kenneth S. Plante +8 more
openaire +2 more sources
Retraction: Oleandrin: A cardiac glycosides with potent cytotoxicity
[This retracts the article on p. 131 in vol. 7, PMID: 24347921.].
openaire +3 more sources
Background: Herbal medicine plays a vital role in healthcare, but safety concerns arise due to potential toxicity risks. Nerium indicum (夹竹桃, jiā zhú táo) is used in Chinese herbal medicine for its therapeutic effects, yet it contains toxic cardiac ...
Veerkumar P. Japti +7 more
doaj +1 more source
EFFECT OF ACTIVE MOLLUSCICIDAL COMPONENETS OF ABRUS PRECATORIUS, ARGEMONE MEXICANA AND NERIUM INDICUM ON CERTAIN ENZYMES IN THE NERVOUS TISSUE OF LYMNAEA ACUMINATA [PDF]
In vivo and in vitro sublethal exposure of abrin, glycyrrhizin (active component of Abrus precatorius seed and root), sanguinarine, protopine (Argemone mexicana seed) and oleandrin (Nerium indicum leaf) inhibited the acetylcholinesterase, lactic ...
doaj
Preliminary investigation of the safe dose of oleandrin when administered orally to Beagles
Abstract OBJECTIVE The purpose of the study reported herein was to determine the dose of oleander extract and oleandrin (the key pharmacologically active constituent) that could be safely administered PO to dogs. ANIMALS 42 purebred Beagle dogs were used to study an extract of Nerium oleander.
Theresa W, Fossum +2 more
openaire +2 more sources
Small molecule regulators of microRNAs identified by high-throughput screen coupled with high-throughput sequencing. [PDF]
Nguyen LD +11 more
europepmc +1 more source
Yellow oleander (Thevetia peruviana) toxicosis in 4 goats. [PDF]
Sykes CA +3 more
europepmc +1 more source
Kathleen F Benson,1 Robert A Newman,2,3 Gitte S Jensen1 1NIS Labs, Klamath Falls, OR, 2Department of Experimental Therapeutics, University of Texas MD Anderson Cancer Center, Houston, 3Nerium Biotechnology Inc, San Antonio, TX, USA Objective: To evaluate
Benson KF, Newman RA, Jensen GS
doaj

